Showing results (581-590 of 3,007) with videos related to

Sort By:
Pageof 301
Basic & Clinical Pharmacology & Toxicology|April 12, 2017
Therapeutic Drug Monitoring of Venlafaxine in an Everyday Clinical Setting: Analysis of Age, Sex and Dose Concentration RelationshipsMorten Rix Hansen, Ida Berglund Kuhlmann, Anton Pottegård, et al.
Basic & Clinical Pharmacology & Toxicology|May 10, 2014
Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre studyPetra Langerová, Jiří Vrtal, Karel Urbánek
Basic & Clinical Pharmacology & Toxicology|March 28, 2019
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapiesMarcus J P Geist, Nelly Siller, Gerlinde Egerer, et al.
Basic & Clinical Pharmacology & Toxicology|October 31, 2012
Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosisWoo-Ram Lee, Kyung-Hyun Kim, Hyun-Jin An, et al.
Basic & Clinical Pharmacology & Toxicology|January 28, 2014
Induction of neurotrophic and differentiation factors in neural stem cells by valproic acidWalaa Almutawaa, Na Hyea Kang, Yi Pan, et al.
Basic & Clinical Pharmacology & Toxicology|January 28, 2014
High-content analysis/screening for predictive toxicology: application to hepatotoxicity and genotoxicityMikael Persson, Anni F Løye, Mélanie Jacquet, et al.
Basic & Clinical Pharmacology & Toxicology|May 28, 2014
Geraniol blocks calcium and potassium channels in the mammalian myocardium: useful effects to treat arrhythmiasJosé Evaldo Rodrigues de Menezes-Filho, Antônio Nei Santana Gondim, Jader Santos Cruz, et al.
Basic & Clinical Pharmacology & Toxicology|November 6, 2012
Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseasesMarjan Gharagozloo, Elahe N Javid, Abbas Rezaei, et al.
Pageof 301